Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase III trial of D-2570 in moderate to severe plaque psoriasis
CTR20252503Phase 3Active
- Sponsor
- InventisBio
- Start
- Sep 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of D-2570 in plaque psoriasis, sponsored by InventisBio. Started Sep 2025; status: active.
02
Drugs
D-2570
03
Conditions
plaque psoriasis
Beyond the preview
Go deeper on CTR20252503.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20252503.